Matthias Meinhardt

Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma

Alexander Scholz, Patrick N. Harter, Sebastian Cremer et al. · EMBO Molecular Medicine · 2015 · 170 citations · Full text

Medicine, Neurology, Oncology +17

Intratumoral heterogeneity and <i>TERT</i> promoter mutations in progressive/higher-grade meningiomas

Tareq A. Juratli, Christian Thiede, Mara V.A. Koerner et al. · Oncotarget · 2017 · 126 citations · Full text

Medicine, Molecular Biology, Oncology +12

Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases

Patrick N. Harter, Simon Bernatz, Alexander Scholz et al. · Oncotarget · 2015 · 124 citations · Full text

Medicine, Immunology, Oncology +17

CD31, EDNRB and TSPAN7 are promising prognostic markers in clear‐cell renal cell carcinoma revealed by genome‐wide expression analyses of primary tumors and metastases

Daniela Wuttig, Stefan Zastrow, S. Füssel et al. · International Journal of Cancer · 2011 · 113 citations

Medicine, Cancer Biology, Oncology +17

<i>TERT</i> Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with <i>IDH</i> Wild-Type Glioblastomas: A Pilot Prospective Study

Tareq A. Juratli, Sebastian Stasik, Amir Zolal et al. · Clinical Cancer Research · 2018 · 109 citations · Full text

Medicine, Genetics, Oncology +17